Search results
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 3 hours agoFor the deal, AbbVie will pay $150 million in upfront and near-term milestone payments to FutureGen,...
The Supreme Court upholds access to mifepristone in a unanimous decision on abortion
Fortune via Yahoo Finance· 4 hours agoThe case, FDA v. Alliance for Hippocratic Medicine, had rallied the pharmaceutical industry, which...
FDA grants orphan drug status to tafenoquine for babesiosis By Investing.com
Investing.com· 3 days agoThe U.S. Food and Drug Administration (FDA) has awarded orphan drug designation to 60 Degrees ...
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 1 day agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Syndax reports encouraging results from AML treatment trials By Investing.com
Investing.com· 2 hours agoSyndax Pharmaceuticals (NASDAQ: NASDAQ:SNDX), a clinical stage biopharmaceutical company, has...
Vertex says Casgevy benefit extends to nearly five years in sickle cell disease
Clinical Trials Arena via Yahoo Finance· 2 hours agoVertex Pharmaceuticals has reported long-term data for its gene therapy Casgevy (exa-cel) in...
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe latest development comes after AstraZeneca‘s supplemental new drug application for Tagrisso...
Leo’s single-dose autoinjector secures FDA approval for atopic dermatitis
Pharmaceutical Technology via Yahoo Finance· 1 day agoAccording to GlobalData’s analysts, atopic dermatitis presents a mine of opportunities, particularly...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 5 hours agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
SCOTUS ruling on mifepristone could have lasting impact on FDA regulation: Experts
ABC7 News· 5 hours agoThe court unanimously struck down a lawsuit seeking to restrict nationwide access to mifepristone,...